Lung cancer is the number one cause of cancer-related deaths for both men and women in the United States. For women in Europe, breast cancer is their biggest death threat – but not for long.

The US Food and Drug Administration has given ibrutinib an accelerated pathway to approval. Ibrutinib is an investigational drug designed to treat two lymphomas.

People diagnosed with chronic myeloid leukemia (CML) are living longer than ever before. A number of effective therapies are available for all phases of the disease, but living with CML has its challenges.

Triple-negative breast cancer is so tough to beat because there are few treatment options. Scientists have uncovered more about how triple-negative breast cancer behaves, and these findings could improve the outlook for patients.

Being treated for prostate cancer can be grueling. The side effects of therapy used to block hormones that feed the cancer definitely impact a man’s quality of life. Some relief is in sight, though.

Research is more often showing that all cancers don’t necessarily have to be treated right away. In fact, watchful waiting may be preferable for some tumors. Kidney cancer appears to fall into this category.

You don’t hear much about stomach (gastric) cancer in this country. But cancer of the stomach is the second leading cancer-related death in the world. Researchers are looking at ways to prevent this cancer altogether.

Living beyond lung cancer is generally tied to the stage at which it’s detected. But what if survival rates weren’t tied to time of diagnosis, but rather where you lived?

What if the odds of beating ovarian cancer could be improved by tinkering with existing chemotherapies? Tweaking chemo regimens may help patients who become resistant to initial therapies.

Sometimes genetics just aren’t fair. Exercise helps everybody. When it comes to reducing prostate cancer risks, though, there’s good news for some men, but not so much for others.